The store will not work correctly when cookies are disabled.
5-(3-Pyridin-3-yl-allylidene)-2-thioxo-dihydro-pyrimidine-4,6-dione
ID: ALA4176101
PubChem CID: 117931617
Max Phase: Preclinical
Molecular Formula: C12H9N3O2S
Molecular Weight: 259.29
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1NC(=S)NC(=O)C1=C/C=C/c1cccnc1
Standard InChI: InChI=1S/C12H9N3O2S/c16-10-9(11(17)15-12(18)14-10)5-1-3-8-4-2-6-13-7-8/h1-7H,(H2,14,15,16,17,18)/b3-1+
Standard InChI Key: YHNNYZJHKOLXBZ-HNQUOIGGSA-N
Molfile:
RDKit 2D
18 19 0 0 0 0 0 0 0 0999 V2000
6.2642 -9.8752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9720 -9.4677 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6839 -9.8752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6839 -10.6943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9720 -11.1018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2642 -10.6943 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3916 -9.4677 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.9720 -11.9209 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.5564 -9.4677 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.3916 -11.1018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0994 -10.6943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8072 -11.1018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2269 -11.1018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5191 -10.6943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5191 -9.8752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2269 -9.4677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9346 -9.8752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9346 -10.6943 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
1 6 1 0
3 7 2 0
5 8 2 0
1 9 2 0
10 11 1 0
11 12 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
13 18 2 0
12 14 1 0
4 10 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 259.29 | Molecular Weight (Monoisotopic): 259.0415 | AlogP: 0.55 | #Rotatable Bonds: 2 |
Polar Surface Area: 71.09 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.44 | CX Basic pKa: 4.88 | CX LogP: 0.98 | CX LogD: 0.71 |
Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.46 | Np Likeness Score: -0.94 |
References
1. Ramisetti SR, Pandey MK, Lee SY, Karelia D, Narayan S, Amin S, Sharma AK.. (2018) Design and synthesis of novel thiobarbituric acid derivatives targeting both wild-type and BRAF-mutated melanoma cells., 143 [PMID:29133035] [10.1016/j.ejmech.2017.11.006] |